Get started
Author

Kim De Veirman

Observed names: De Veirman, Kim, K De Veirman, K. De Veirman, Kim de Veirman, de Veirman, Kim
Observed institutions: Vrije Universiteit Brussel, Inserm, Tianjin Medical University General Hospital, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Universitair Ziekenhuis Brussel, Centre de Recherche Saint-Antoine, Tianjin Medical University
ORCID: 0000-0002-1313-6121
Observed ORCID: 0000-0002-1313-6121
OpenAlex ID: A5069262831
Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression
2016 · Jinheng Wang, Kim De Veirman, et al. · The Journal of Pathology · 231
Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts
2018 · Sylvia Faict, Joséphine Muller, et al. · Blood Cancer Journal · 154
The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells
2015 · Jinheng Wang, Kim De Veirman, et al. · Oncotarget · 153
PDF
A niche-dependent myeloid transcriptome signature defines dormant myeloma cells
2019 · Weng Hua Khoo, Guy Ledergor, et al. · Blood · 138
Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity
2016 · Kim De Veirman, Jinheng Wang, et al. · Cancer Letters · 138
Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
2018 · Song Xu, Kim De Veirman, et al. · Leukemia · 111
PDF
Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
2014 · Kim De Veirman, Els Van Valckenborgh, et al. · Frontiers in Oncology · 95
PDF
Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment
2023 · Hannah Egan, Oliver Treacy, et al. · Cell Reports · 94
PDF
Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma
2016 · Marilène Binsfeld, Joséphine Muller, et al. · Oncotarget · 93
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma
2014 · Kim De Veirman, Luigia Rao, et al. · Cancers · 84
PDF
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients
2015 · M A Frassanito, K De Veirman, et al. · Leukemia · 82
Upregulation of miR-135b Is Involved in the Impaired Osteogenic Differentiation of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients
2013 · Song Xu, Gaia Cecilia Santini, et al. · PLoS ONE · 82
PDF
Metabolic Features of Multiple Myeloma
2018 · Chaima El Arfani, Kim De Veirman, et al. · International Journal of Molecular Sciences · 75
PDF
Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells
2015 · Kim De Veirman, Jo A. Van Ginderachter, et al. · Oncotarget · 70
PDF
Tumour‐associated macrophage‐mediated survival of myeloma cells through STAT3 activation
2016 · Nathan De Beule, Kim De Veirman, et al. · The Journal of Pathology · 69
Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo
2013 · Song Xu, Kim De Veirman, et al. · Acta Pharmacologica Sinica · 64
The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response
2018 · Eva De Smedt, Hui Lui, et al. · Frontiers in Oncology · 61
PDF
The antigen‐binding moiety in the driver's seat of CARs
2021 · Heleen Hanssens, Fien Meeus, et al. · Medicinal Research Reviews · 60
PDF
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway
2018 · Kim De Veirman, Eline Menu, et al. · Cancer Letters · 60
Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion
2017 · Kim De Veirman, Nathan De Beule, et al. · Cancer Immunology Research · 57
The therapeutic potential of cell cycle targeting in multiple myeloma
2017 · Anke Maes, Eline Menu, et al. · Oncotarget · 57
PDF
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
2022 · Emma Verheye, Jesús Bravo Melgar, et al. · International Journal of Molecular Sciences · 55
PDF
Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway
2012 · S Xu, H Evans, et al. · Leukemia · 55
Fueling CARs: metabolic strategies to enhance CAR T-cell therapy
2024 · Arne Van der Vreken, Karin Vanderkerken, et al. · Experimental Hematology and Oncology · 54
The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma
2019 · Sylvia Faict, Inge Oudaert, et al. · Cancers · 54
PDF
Works count: 184
Citation count: 3,135
H-index: 32
I10-index: 57
Year
Topic
Type